Assignee
GENOSCIENCE PHARMA
FR4 patents
Top patents by PatentIndex Score
US10179770B2Jan 15, 2019
Quinolines derivatives as novel anticancer agents
GENOSCIENCE PHARMA1 citations50
US11261189B2Mar 1, 2022
Substituted 2,4 diamino-quinoline as new medicament for fibrosis, autophagy and cathepsins B (CTSB), L (CTSL) and D (CTSD) related diseases
GENOSCIENCE PHARMA0 citations38
US10577362B2Mar 3, 2020
Substituted 2, 4-diamino-quinoline derivatives for use in the treatment of proliferative diseases
GENOSCIENCE PHARMA0 citations29
US10722505B2Jul 28, 2020
Substituted 2,4 diamino-quinoline as new anticancer agents
GENOSCIENCE PHARMA0 citations27